European Commission Adopts Regulation to Counter Potential US Tariffs

1 minute

On 24 July 2025, the European Commission adopted Implementing Regulation (EU) 2025/1564, reintroducing commercial rebalancing measures against the United States in response to ongoing US safeguard tariffs on EU exports.

The move follows the expiration of a prior suspension agreement (for previous coverage, seeEU Suspends Retaliatory Tariffs for Goods from US Until 6 August 2025 (15 July 2025)) and aims to counteract economic harm caused by Section 232 of the United States’ Trade Expansion Act and the tariffs imposed on steel and aluminium, passenger vehicles and light trucks, and on certain automobile parts, and on a wide range of other products. The Commission may revise the regulation if the United States adjusts its tariff regime (for prior coverage, see European Commission Suspends Tariff Countermeasures for 90 days After US Tariff Pause (10 April 2025)).

For now, however, as an answer to President Trump’s “Reciprocal Tariff Policy”, the European Union is imposing:

  • additional ad valorem duties (0%–30%) on a wide range of US-origin imports;
  • export bans on selected EU goods destined for the United States; and
  • duty suspensions for military and humanitarian goods.

These measures are detailed in Annexes I–XIV of Implementing Regulation (EU) 2025/1564 and will be phased in from 7 August 2025 to 7 February 2026.

More information relating to tariff measures can be found on IBFD's International Guide on Global Trade.

Related

Tax News
Other Taxes, Specific Sectors, Tariffs

United States to Remove Tariffs on UK Pharmaceuticals, Suspend Section 301 Actions under New Trade Deal

The United States will exempt UK-origin pharmaceuticals, pharmaceutical ingredients, and medical technology from section 232 tariffs and suspend future section 301 actions targeting UK pharmaceutical pricing practices for the duration of President Trump's term, under a new bilateral agreement in principal announced on 1 December 2025.The Office of the United States Trade Representative (USTR), together with the Departments of Commerce and Health and Human Services, confirmed in a 1 December 2025 news release that the tariff exemptions form part of a broader US–UK Economic Prosperity Deal (EPD). The agreement aims to address long-standing imbalances in pharmaceutical trade and foster innovation and investment in both countries.
2 minutes

Mexico Adopts 2026 Economic Package Containing Various Tax Measures

Mexico has adopted the Economic Package for fiscal year 2026 which was submitted earlier this year. The final version includes additional measures beyond those proposed in the initial draft. For previous reporting, see Economic Package for 2026: Executive Branch Proposes Amendments to Tax Incentives, New Obligations for Digital Platforms (12 September 2025).The main changes concern measures related to excise taxes, real-time access to digital platforms information, and tax incentives for the insurance sector. They are as follows:
2 minutes
Tax News
Tariffs, Tax Treaties

US Begins Investigation Into China's Compliance With Phase One Trade Agreement

The Office of the US Trade Representative (USTR) has begun an investigation into China's compliance with the Phase One economic and trade agreement. The USTR began the investigation on 24 October 2025, after finding an "apparent failure to comply" with the terms of the agreement.
2 minutes